<DOC>
	<DOC>NCT00616993</DOC>
	<brief_summary>The purpose of this phase III study is to determine the safety and efficacy of difluprednate in the treatment of inflammation following ocular surgery.</brief_summary>
	<brief_title>Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-004)</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Difluprednate</mesh_term>
	<mesh_term>Fluprednisolone</mesh_term>
	<criteria>Scheduled for unilateral ocular surgery. Systemic administration of any corticosteroid or immunosuppressive drug in the 2 weeks prior to study enrollment.</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>